Role of Base Excision Repair in Limiting Hepatocellular Carcinomas -Administrative Supplement
碱基切除修复在限制肝细胞癌中的作用 - 行政补充
基本信息
- 批准号:10378947
- 负责人:
- 金额:$ 22.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-01 至 2024-10-31
- 项目状态:已结题
- 来源:
- 关键词:Administrative SupplementAffectAflatoxin B1AflatoxinsAfrica South of the SaharaAmericasAutomobile DrivingBase Excision RepairsBiochemicalBiochemical PathwayBiologicalCRISPR/Cas technologyCancer EtiologyCell LineCellsCentral AmericaCessation of lifeChinaChronicComplexCountyDNADNA AdductsDNA BindingDNA DamageDNA RepairDNA Repair DisorderDNA Repair PathwayDNA SequenceDNA glycosylaseDNA sequencingDataDatabasesDevelopmentDiagnosticDiseaseEngineeringEnvironmental HealthEnvironmental Risk FactorEtiologyEuropeanEventExcisionExposure toFapy-dGFar EastFrequenciesFundingGenetic Predisposition to DiseaseGenetic VariationGenotypeGeographic DistributionGeographyGoalsGrainHealthHepatitis BHepatitis B IncidenceHepatitis B Surface AntigensHepatitis B VirusHeterozygoteHumanIncidenceIndividualInflammationIngestionInvestigationKnock-outKnowledgeLaboratoriesLiverLiver neoplasmsMalignant NeoplasmsMalignant neoplasm of liverMeasuresMolecularMusMutagenesisMutationMycotoxinsNucleotide Excision RepairNucleotidesNutsOncogenicOnset of illnessPathway interactionsPhenotypePopulationPopulations at RiskPredispositionPrimary carcinoma of the liver cellsPropertyProteinsReactionReportingRiskRisk FactorsRoleSouth AmericaStructureSurface AntigensTestingTissuesTransgenic MiceTranslatingVariantVirus Diseasesadductaflatoxin B1-DNA adductbasecarcinogenesiscohortdesigndietaryearly onseteffective therapyepidemiology studyexome sequencingfungusgene repairgenetic risk factorgenetic variantgenotoxicityglobal environmentglobal healthmortalitymouse modelpopulation basedprimary endpointrepair enzymerepairedresponsestressortooltumor DNAvirtual
项目摘要
Summary for Administrative Supplemental Funding Request
The combination of chronic dietary exposure to the fungal toxin, aflatoxin B1 (AFB1), and hepatitis B viral (HBV)
infection is associated with a significant increased risk for early onset hepatocellular carcinomas (HCCs) in
millions of people living in East Asia, Central and South America, and sub-Saharan Africa. Even though dietary
exposures to aflatoxins constitute the second largest global environmental risk factor for cancer development,
there are still significant questions concerning the molecular mechanisms driving carcinogenesis. In-depth
knowledge of these mechanisms is critical for the identification of genetic risk factors that affect individual
susceptibility for people who are HBV infected and AFB1 exposed. In this regard, since AFB1 carcinogenesis is
driven by high frequency mutagenesis of G to T transversions, the DNA repair pathways that initiate and
complete repair of persistent AFB1-induced DNA adducts and base damage from HBV-induced inflammation
have strong biological significance. These pathways define the mutagenic burden in the target tissues and
ultimately limit cellular progression to cancer. Although the nucleotide excision repair (NER) pathway has been
shown to repair AFB1 DNA adducts, murine data presented herein demonstrate that knockout of the DNA base
excision repair (BER) pathway, initiated by the DNA glycosylase NEIL1, is significantly more important than
NER relative to the removal of the highly mutagenic AFB1-Fapy-dG adducts. Thus, our data suggest that
deficiencies in NEIL1 could contribute to the initiation of HCCs in humans. To maximize relevance to human
health, all known variants of NEIL1 will be characterized from regions of the world where aflatoxin ingestion
and HBV infection are prevalent. All variants will be characterized for their biochemical properties relative to
WT NEIL1 and expressed in cells and transgenic mice to understand the potential for catalytically-
compromised variants of NEIL1 to alter susceptibility to aflatoxin exposures. These aims will test the
hypothesis that expression of the oncogenic and other catalytically-compromised variants of NEIL1 can
efficiently block repair and promote increased mutagenesis and carcinogenesis. Characterization of
phenotypically dominant oncogenic variants of NEIL1 will provide the molecular basis from which to design
human epidemiological studies in at-risk populations and early onset HCC cohorts. Further, this application
proposes to establish the molecular mechanisms by which the combination of chronic inflammation driven by
the hepatitis B surface antigen and deficiencies in DNA repair could synergistically drive AFB1-induced
mutagenesis and carcinogenesis. Overall, these studies have direct human health relevance pertaining to
understanding a global environmental health problem by identifying genetic risk factors and biochemical
pathways previously not recognized as germane to AFB1-induced carcinogenesis.
行政补充资金请求的摘要
慢性饮食暴露于真菌毒素,黄曲霉毒素B1(AFB1)和乙型肝炎病毒(HBV)的结合(HBV)
感染与早期发作肝癌(HCC)的风险显着增加有关
数百万居住在东亚,中美洲和南美以及撒哈拉以南非洲的人。即使饮食
对黄曲霉毒素的暴露构成了癌症发展的第二大全球环境风险因素,
关于驱动癌变的分子机制,仍然存在重大问题。深入
对这些机制的了解对于鉴定影响个体的遗传风险因素至关重要
对感染HBV的人的敏感性和暴露的AFB1。在这方面,由于AFB1癌变是
由G到T横向的高频诱变驱动,T trypersions(启动和
持续的AFB1诱导的DNA加合物和HBV诱导的炎症的基本损害的完全修复
具有强大的生物学意义。这些途径定义了目标组织中的诱变负担
最终将细胞进展限制为癌症。尽管核苷酸切除修复(NER)途径已经
显示了用于修复AFB1 DNA加合物,此处介绍的鼠数据表明DNA碱基的敲除
由DNA糖基酶Neil1发起的切除修复(BER)途径比
相对于去除高度诱变的AFB1-FAPY-DG加合物的NER。因此,我们的数据表明
Neil1中的缺陷可能有助于人类的HCC启动。最大化与人的相关性
健康,Neil1的所有已知变体将以世界各地的摄入量为特征
HBV感染很普遍。所有变体的生化特性相对于它们的生化特性都将被表征
wt neil1并在细胞和转基因小鼠中表达,以了解催化的潜力
尼尔1的变体破坏了对黄曲霉毒素暴露的敏感性。这些目标将测试
假设Neil1的致癌性和其他催化作用变体的表达
有效阻止修复并促进诱变和致癌作用增加。表征
尼尔1的表型主导的致癌变异将提供分子基础。
人类的流行病学研究和早期发作HCC队列。此外,此应用程序
提议建立分子机制,慢性炎症的组合由
乙型肝炎表面抗原和DNA修复中的缺陷可以协同驱动AFB1诱导
诱变和癌变。总体而言,这些研究具有与人类健康有关的直接相关性
通过识别遗传危险因素和生化来了解全球环境健康问题
以前未被认为是AFB1诱导的致癌作用的途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
R. Stephen Lloyd其他文献
Site-directed mutagenesis of the T4 endonuclease V gene: role of lysine-130.
T4 核酸内切酶 V 基因的定点诱变:赖氨酸 130 的作用。
- DOI:
10.1021/bi00406a006 - 发表时间:
1988 - 期刊:
- 影响因子:2.9
- 作者:
Adrian Recinos;R. Stephen Lloyd - 通讯作者:
R. Stephen Lloyd
Site-directed mutagenesis of the T4 endonuclease V gene: role of tyrosine-129 and -131 in pyrimidine dimer-specific binding.
T4 核酸内切酶 V 基因的定点诱变:酪氨酸 129 和 -131 在嘧啶二聚体特异性结合中的作用。
- DOI:
10.1021/bi00406a007 - 发表时间:
1988 - 期刊:
- 影响因子:2.9
- 作者:
Donald G. Stump;R. Stephen Lloyd - 通讯作者:
R. Stephen Lloyd
Mutagenic bypass of the butadiene-derived 2′-deoxyuridine adducts by polymerases η and ζ
- DOI:
10.1016/j.mrfmmm.2007.05.003 - 发表时间:
2007-12-01 - 期刊:
- 影响因子:
- 作者:
Priscilla H. Fernandes;R. Stephen Lloyd - 通讯作者:
R. Stephen Lloyd
R. Stephen Lloyd的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('R. Stephen Lloyd', 18)}}的其他基金
Role of Base Excision Repair in Limiting Hepatocellular Carcinomas
碱基切除修复在限制肝细胞癌中的作用
- 批准号:
10292967 - 财政年份:2020
- 资助金额:
$ 22.25万 - 项目类别:
Role of Base Excision Repair in Limiting Hepatocellular Carcinomas
碱基切除修复在限制肝细胞癌中的作用
- 批准号:
10513822 - 财政年份:2020
- 资助金额:
$ 22.25万 - 项目类别:
DNA Repair Deficiency Associated with Obesity and the Metabolic Syndrome
与肥胖和代谢综合征相关的 DNA 修复缺陷
- 批准号:
7728334 - 财政年份:2009
- 资助金额:
$ 22.25万 - 项目类别:
DNA Repair Deficiency Associated with Obesity and the Metabolic Syndrome
与肥胖和代谢综合征相关的 DNA 修复缺陷
- 批准号:
8098171 - 财政年份:2009
- 资助金额:
$ 22.25万 - 项目类别:
T4 Endonuclease V Structure-Function Analysis
T4 核酸内切酶 V 结构功能分析
- 批准号:
7911342 - 财政年份:2009
- 资助金额:
$ 22.25万 - 项目类别:
DNA Repair Deficiency Associated with Obesity and the Metabolic Syndrome
与肥胖和代谢综合征相关的 DNA 修复缺陷
- 批准号:
8453441 - 财政年份:2009
- 资助金额:
$ 22.25万 - 项目类别:
DNA Repair Deficiency Associated with Obesity and the Metabolic Syndrome
与肥胖和代谢综合征相关的 DNA 修复缺陷
- 批准号:
8249438 - 财政年份:2009
- 资助金额:
$ 22.25万 - 项目类别:
DNA Repair Deficiency Associated with Obesity and the Meatbolic Syndrome
与肥胖和代谢综合征相关的 DNA 修复缺陷
- 批准号:
7387067 - 财政年份:2007
- 资助金额:
$ 22.25万 - 项目类别:
相似国自然基金
酶法降解花生粕中黄曲霉毒素B1的机理及对花生粕品质的影响
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
酶法降解花生粕中黄曲霉毒素B1的机理及对花生粕品质的影响
- 批准号:32172135
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
基于可视化检测方法研究Bolt区对Trametes coccinea AFB1降解酶催化性能的影响机制
- 批准号:31802103
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
黄曲霉中SUMO化修饰对黄曲霉毒素B1生物合成过程的影响及其机制
- 批准号:31700050
- 批准年份:2017
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
黄曲霉毒素B1对肿瘤细胞IGF1受体/IRS2信号通路及细胞迁移的影响
- 批准号:81272215
- 批准年份:2012
- 资助金额:65.0 万元
- 项目类别:面上项目
相似海外基金
Studies of Chemically Labile Alkylation Damage in DNA
DNA 中化学不稳定烷基化损伤的研究
- 批准号:
10735154 - 财政年份:2023
- 资助金额:
$ 22.25万 - 项目类别:
Studies of Chemically Labile Alkylation Damage in DNA
DNA 中化学不稳定烷基化损伤的研究
- 批准号:
10769108 - 财政年份:2023
- 资助金额:
$ 22.25万 - 项目类别:
Aflatoxin Exposure, Growth Faltering, and the Gut Microbiome among Children in Rural Guatemala
危地马拉农村儿童的黄曲霉毒素暴露、生长迟缓和肠道微生物组
- 批准号:
10586566 - 财政年份:2023
- 资助金额:
$ 22.25万 - 项目类别:
Project 4: Interrogating and harnessing age-related IFN signaling and innate immunity in HCC prevention and therapy
项目 4:在 HCC 预防和治疗中探究和利用与年龄相关的 IFN 信号传导和先天免疫
- 批准号:
10698110 - 财政年份:2021
- 资助金额:
$ 22.25万 - 项目类别:
Project 4: Interrogating and harnessing age-related IFN signaling and innate immunity in HCC prevention and therapy
项目 4:在 HCC 预防和治疗中探究和利用与年龄相关的 IFN 信号传导和先天免疫
- 批准号:
10270689 - 财政年份:2021
- 资助金额:
$ 22.25万 - 项目类别: